日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease

白藜芦醇可减轻阿尔茨海默病患者脑脊液中神经退行性变和神经炎症的标志物

Liu, Xiaoguang; Baxley, Sean; Hebron, Michaeline; Turner, Raymond Scott; Moussa, Charbel

A Novel Small Molecule Enhances Stable Dopamine Delivery to the Brain in Models of Parkinson's Disease.

一种新型小分子可增强帕金森病模型中大脑内多巴胺的稳定输送

Liu Xiaoguang, Hebron Michaeline L, Stevenson Max, Moussa Charbel

Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib

尼洛替尼治疗路易体痴呆患者的安全性、认知和行为结果

Pagan, Fernando; Torres-Yaghi, Yasar; Hebron, Michaeline; Wilmarth, Barbara; Turner, R Scott; Matar, Sara; Liu, Xiaoguang; Ferrante, Dalila; Esposito, Giuseppe; Ahn, Jaeil; Moussa, Charbel

Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes

酪氨酸激酶:位于多种神经退行性疾病相关过程交汇处的多功能受体

Stevenson, Max; Algarzae, Norah K; Moussa, Charbel

Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer's disease

尼洛替尼抑制盘状结构域受体(DDR)-1可改变脑脊液miRNA,并与阿尔茨海默病患者的炎症和血管纤维化减轻有关。

Stevenson, Max; Varghese, Rency; Hebron, Michaeline L; Liu, Xiaoguang; Ratliff, Nick; Smith, Amelia; Turner, R Scott; Moussa, Charbel

Correction: Parkin ubiquitinates TAR-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6)

更正:Parkin 泛素化 TAR-DNA 结合蛋白-43 (TDP-43),并通过与组蛋白去乙酰化酶 6 (HDAC6) 相互作用促进其在胞质中的积累。

Hebron, Michaeline L; Lonskaya, Irina; Sharpe, Kaydee; Weerasinghe, Puwakdandawe P K; Algarzae, Norah K; Shekoyan, Ashot R; Moussa, Charbel E-H

The Sigma Enigma: A Narrative Review of Sigma Receptors

西格玛之谜:西格玛受体的叙述性综述

Pergolizzi, Joseph; Varrassi, Giustino; Coleman, Mark; Breve, Frank; Christo, Dana K; Christo, Paul J; Moussa, Charbel

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies

博舒替尼治疗路易体痴呆的安全性、靶点结合率和生物标志物效应

Pagan, Fernando L; Torres-Yaghi, Yasar; Hebron, Michaeline L; Wilmarth, Barbara; Turner, R Scott; Matar, Sara; Ferrante, Dalila; Ahn, Jaeil; Moussa, Charbel

Not all dementias are equally created: Tailored translational research differentially addresses unanswered questions

并非所有痴呆症的成因都相同:有针对性的转化研究针对不同的未解之谜。

Moussa, Charbel

Erratum to: Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases

更正:盘状结构域受体 1 是神经退行性疾病的治疗靶点

Fowler, Alan J; Hebron, Michaeline; Balaraman, Kaluvu; Shi, Wangke; Missner, Alexander A; Greenzaid, Jonathan D; Chiu, Timothy L; Ullman, Clementina; Weatherdon, Ethan; Duka, Val; Torres-Yaghi, Yasar; Pagan, Fernando L; Liu, Xiaoguang; Ressom, Habtom; Ahn, Jaeil; Wolf, Christian; Moussa, Charbel